References
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- TangDNaganoHNakamuraMClinical and pathological features of Allen’s type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinomaJ Gastrointest Surg200610798799816843869
- GeorgeJPatelTNoncoding RNA as therapeutic targets for hepatocellular carcinomaSemin Liver Dis2015351637425632936
- KlingenbergMMatsudaADiederichsSPatelTNon-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targetsJ Hepatol201767360361828438689
- ShibataCOtsukaMKishikawaTDiagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinomaWorld J Hepatol2015711625624991
- AmbrosVThe functions of animal microRNAsNature2004431700635035515372042
- BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
- SempereLFIntegrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancerExpert Rev Mol Diagn201111881382722022944
- LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature2005435704383483815944708
- WangZLiXThe role of noncoding RNA in hepatocellular carcinomaGland Surg201321252925083452
- Cancer Genome Atlas Research NetworkWeinsteinJNCollissonEAThe Cancer Genome Atlas pan-cancer analysis projectNat Genet201345101113112024071849
- TomczakKCzerwińskaPWiznerowiczMThe Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeContemp Oncol (Pozn)2015191AA68A7725691825
- Cancer Genome Atlas Research Network. Electronic address: [email protected]; Cancer Genome Atlas Research NetworkComprehensive and integrative genomic characterization of hepatocellular carcinomaCell201716971327.e231341.e2328622513
- RobinsonMDMcCarthyDJSmythGKedgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics201026113914019910308
- LiaoXHuangKHuangRGenome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyOnco Targets Ther2017104493450628979141
- ZhouMZhaoHWangZIdentification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myelomaJ Exp Clin Cancer Res20153410226362431
- ZhouMSunYSunYComprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancerOncotarget2016722324333244827074572
- AgarwalVBellGWNamJWBartelDPPredicting effective microRNA target sites in mammalian mRNAsElife20154138
- WongNWangXmiRDB: an online resource for microRNA target prediction and functional annotationsNucleic Acids Res201543 Database issueD146D15225378301
- ChouCHShresthaSYangCDmiRTarBase update 2018: a resource for experimentally validated microRNA-target interactionsNucleic Acids Res201846D1D296D30229126174
- ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
- DennisGJrShermanBTHosackDADAVID: database for annotation, visualization, and integrated discoveryGenome Biol200345P312734009
- BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ Roy Statist Soc Series B Stat Methodol1995571289300
- ReinerAYekutieliDBenjaminiYIdentifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics200319336837512584122
- BenjaminiYDraiDElmerGKafkafiNGolaniIControlling the false discovery rate in behavior genetics researchBehav Brain Res20011251–227928411682119
- LiangLWeiDMLiJJPrognostic microRNAs and their potential molecular mechanism in pancreatic cancer: a study based on The Cancer Genome Atlas and bioinformatics investigationMol Med Rep201817193995129115476
- ZhouXHuangZXuLA panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancerOncotarget2016743696166962427626307
- DingBGaoXLiHLiuLHaoXA novel microRNA signature predicts survival in stomach adenocarcinomaOncotarget2017817281442815328423653
- WongNKhwajaSSBakerCMPrognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomasCancer Med2016571619162827109697
- ShiHChenJLiYIdentification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinomaOncotarget2016716215792159026933913
- YanWLiRLiuYMicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosisOncotarget2014524129081291525415048
- LiRGaoKLuoHIdentification of intrinsic subtype-specific prognostic microRNAs in primary glioblastomaJ Exp Clin Cancer Res201433924438238
- WangZBaoZYanWIsocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild typeJ Exp Clin Cancer Res2013325923988086
- HayesJThygesenHTumilsonCPrediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signatureMol Oncol20159370471425499534
- LiangBLiYWangTA three miRNAs signature predicts survival in cervical cancer using bioinformatics analysisSci Rep201771562428717180
- ZhouHTangKXiaoHA panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancerJ Exp Clin Cancer Res2015345325991007
- ZhouXWangXHuangZXuLZhuWLiuPAn ER-associated miRNA signature predicts prognosis in ER-positive breast cancerJ Exp Clin Cancer Res2014339425373603
- VoliniaSCroceCMPrognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancerProc Natl Acad Sci U S A2013110187413741723589849
- JacobHStanisavljevicLStorliKEHestetunKEDahlOMyklebustMPIdentification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancerOncotarget2017850878378784729152124
- LiXShiYYinZXueXZhouBAn eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinomaJ Transl Med20141215924893932
- GaoXWuYYuWLiHIdentification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinomaOncotarget2016749816708167927835574
- LuMKongXWangHHuangGYeCHeZA novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisOncotarget2017858775878428060739
- LiuGWangHFuJDLiuJYYanAGGuanYYA five-miRNA expression signature predicts survival in hepatocellular carcinomaAPMIS2017125761462228430373
- ZhangJChongCCChenGGLaiPBA seven-microRNA expression signature predicts survival in hepatocellular carcinomaPLoS One2015106e012862826046780
- ZhouXWenWZhuJA six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinomaOncotarget2017821344683448028380431
- ZhangYSuiJShenXDifferential expression profiles of microR-NAs as potential biomarkers for the early diagnosis of lung cancerOncol Rep20173763543355328498428
- XiongDDLvJWeiKLA nine-miRNA signature as a potential diagnostic marker for breast carcinoma: an integrated study of 1,110 casesOncol Rep20173763297330428440475
- Ab MutalibNSOthmanSNMohamad YusofAAbdullah SuhaimiSNMuhammadRJamalRIntegrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasisPeerJ20164e211927350898
- GiordanoSColumbanoAMicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?Hepatology201357284084723081718
- ZhangQPuRDuYNon-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targetsCancer Lett2012321111222425745
- LiTYinJYuanLDownregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survivalOncol Rep20143141699170624549282
- WangZDingQLiYReanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosisTumour Biol20163711147791478727633066
- GuWLiXWangJmiR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathwayOncol Rep201431139740424190507
- WongCCWongCMTungEKThe microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2Gastroenterology2011140132233120951699
- QiuGLinYZhangHWuDmiR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2Biochem Biophys Res Commun2015463331532126022123
- FanQHeMDengXDerepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinomaCell Biochem Funct201331431932423001723
- WangMWenTFHeLHLiCZhuWJTrishulNMA six-microRNA set as prognostic indicators for bile duct cancerInt J Clin Exp Med2015810172611727026770318
- LiuXDuanBDongYMicroRNA-139-3p indicates a poor prognosis of colon cancerInt J Clin Exp Pathol20147118046805225550849
- HellerGWeinzierlMNollCGenome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancersClin Cancer Res20121861619162922282464
- KitanoKWatanabeKEmotoNCpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancerCancer Sci2011102122126213121917081
- ShimizuTSuzukiHNojimaMMethylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancerEur Urol20136361091110023200812
- HildebrandtMAGuJLinJHsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinomaOncogene201029425724572820676129
- MinorJWangXZhangFMethylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomasOral Oncol2012481737822133638
- PotapovaAAlbatCHasemeierBSystematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolutionBMC Biotechnol201111621235780
- AnwarSLAlbatCKrechTConcordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic markerInt J Cancer2013133366067023364900
- EnknerFPichlhöferBZaharieATMolecular profiling of thymoma and thymic carcinoma: genetic differences and potential novel therapeutic targetsPathol Oncol Res201723355156427844328
- MaZLiHZhengHMicroRNA-101-2-5p targets the ApoB gene in the liver of chicken (Gallus Gallus)Genome201760867367828636837
- BaeJSKimJHPasajeCFAssociation study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseasesDig Liver Dis2012441084985422658643
- ChenJQinZJiangYGenetic variations in the flanking regions of miR-101-2 are associated with increased risk of breast cancerPLoS One201491e8631924475105
- RiquelmeITapiaOLealPmiR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathwayCell Oncol (Dordr)2016391233326458815
- LiCYXiongDDHuangCQClinical value of miR-101-3p and biological analysis of its prospective targets in breast cancer: a study based on The Cancer Genome Atlas (TCGA) and bioinformaticsMed Sci Monit2017231857187128416776
- SannigrahiMKSharmaRPandaNKKhullarMRole of non-coding RNAs in head and neck squamous cell carcinoma: a narrative reviewOral Dis Epub2017921
- YangLYinDWangYCaoLInhibition of the growth of hepatocellular carcinoma cells through fibroblast growth factor 18 suppressed by miR-139Oncol Rep20173842565257128765917
- LuoHYangRLiCMicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogeneTumour Biol2017397101042831771841428720065